Literature DB >> 25207874

Histopathology of duodenal mucosal lesions in pediatric patients with inflammatory bowel disease: statistical analysis to identify distinctive features.

Steven Hardee1, Arik Alper, Dinesh S Pashankar, Raffaella A Morotti.   

Abstract

Histopathologic lesions of the upper gastrointestinal tract (UGT) are common in inflammatory bowel disease (IBD) patients. Pediatric patients have a higher incidence of IBD-associated gastritis and duodenitis than do adults. This study aimed to identify histopathologic features of duodenal lesions in the pediatric population that are characteristic of IBD, compared to duodenal pathology of different etiopathogenesis. We performed a retrospective analysis of UGT biopsies from pediatric patients with a histopathologic diagnosis of duodenitis (0-18 years of age) over a 7-year period. We identified 40 cases of duodenitis associated with Crohn's disease (CD) and 10 cases associated with ulcerative colitis (UC) and compared the histopathologic characteristics of the duodenitis with age-matched controls consisting of 40 cases duodenitis associated with celiac disease and 40 non-Helicobacter pylori-associated (NOS) etiology duodenitis cases. The histologic features that were evaluated included presence of granulomas, duodenal cryptitis, erosion, lamina propria eosinophils, villous blunting, increased intraepithelial lymphocytes (IELs), and crypt hyperplasia, among others. Additionally, we evaluated the presence of associated gastritis in all of these groups. Statistical analysis to identify significant differences was performed using Kruskal-Wallis testing. Cryptitis was the most distinctive feature of IBD-associated duodenitis. Granulomas were exceptionally rare. The severity of villous blunting and presence of IELs was significantly different in the IBD versus the celiac group. There is a significant overlap with duodenal lesions of different etiopathogenesis, including villous blunting and eosinophilia. With the exclusion of granulomas, cryptitis seems the most distinctive feature of the duodenal lesions associated with IBD.

Entities:  

Keywords:  Crohn's; celiac disease; children; duodenitis; inflammatory bowel disease; ulcerative colitis

Mesh:

Year:  2014        PMID: 25207874     DOI: 10.2350/14-07-1529-OA.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  8 in total

1.  Prevalence and Clinical, Endoscopic, and Pathological Features of Duodenitis in Children.

Authors:  Arik Alper; Steven Hardee; Danilo Rojas-Velasquez; Sandra Escalera; Raffaella A Morotti; Dinesh S Pashankar
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-02       Impact factor: 2.839

2.  Unique Regulation of Coupled NaCl Absorption by Inducible Nitric Oxide in a Spontaneous SAMP1/YitFc Mouse Model of Chronic Intestinal Inflammation.

Authors:  Subha Arthur; Balasubramanian Palaniappan; Sheuli Afroz; Uma Sundaram
Journal:  Inflamm Bowel Dis       Date:  2021-10-20       Impact factor: 5.325

Review 3.  Intraepithelial lymphocytes, scores, mimickers and challenges in diagnosing gluten-sensitive enteropathy (celiac disease).

Authors:  Consolato Sergi; Fan Shen; Gerd Bouma
Journal:  World J Gastroenterol       Date:  2017-01-28       Impact factor: 5.742

4.  Anti-inflammatory effects of Fagopyrum cymosum administered as a potential drug for ulcerative colitis.

Authors:  Fei Ge; Shilin Zhu; Lina Liu; Jing Yan; Yu Ji; Zhiguang Sun
Journal:  Exp Ther Med       Date:  2017-09-20       Impact factor: 2.447

5.  Inducible Nitric Oxide Regulates Na-Glucose Co-transport in a Spontaneous SAMP1/YitFc Mouse Model of Chronic Ileitis.

Authors:  Balasubramanian Palaniappan; Shanmuga Sundaram; Subha Arthur; Sheuli Afroz; Uma Sundaram
Journal:  Nutrients       Date:  2020-10-13       Impact factor: 5.717

6.  Upper gastrointestinal tract involvement of Crohn disease: clinical implications in children and adolescents.

Authors:  Eun Sil Kim; Mi Jin Kim
Journal:  Clin Exp Pediatr       Date:  2021-09-10

7.  Farrerol Ameliorates TNBS-Induced Colonic Inflammation by Inhibiting ERK1/2, JNK1/2, and NF-κB Signaling Pathway.

Authors:  Xin Ran; Yuhang Li; Guangxin Chen; Shoupeng Fu; Dewei He; Bingxu Huang; Libin Wei; Yuanqing Lin; Yingcheng Guo; Guiqiu Hu
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923

Review 8.  Upper Gastrointestinal Tract Involvement in Inflammatory Bowel Diseases: Histologic Clues and Pitfalls.

Authors:  Bence Kővári; Rish K Pai
Journal:  Adv Anat Pathol       Date:  2022-01-01       Impact factor: 3.875

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.